Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Raises Design, Training Questions With Surgical Robots

This article was originally published in The Gray Sheet

Executive Summary

The agency is set to hold a workshop on Robotically-Assisted Surgical Devices later this month. In advance, FDA issued a discussion document exploring questions and concerns over how to regulate these devices in the future.

You may also be interested in...



'Open Payments' Peek: Device, DX Company Payments To Physicians Slightly Down In 2016

The latest updates to the US Open Payments database show spending by device and diagnostics firms on physician royalties, consulting fees, education, research and more was a bit less in 2016 compared to 2015, but still substantial. Top "general payment" spending came from Medtronic, Zimmer Biomet, Johnson & Johnson, Stryker, Smith & Nephew and Intuitive Surgical; while top "research payments" were reported by Edwards Lifesciences, Boston Scientific, and Abbott Laboratories, according to the CMS database.

Ethicon Looks To Jumpstart Robotics Program With Google Partnership

The Johnson & Johnson division plans to work with the technology giant to create a robot-assisted minimally invasive surgery platform.

FDA Surgeon Survey Finds Variation In Training With da Vinci System

An FDA survey of 11 surgeons with experience using Intuitive Surgical’s da Vinci robotic surgical system shows respondents reported having difficulty learning how to use the device’s complex user interface.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034050

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel